Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_759_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Foreword
- •Preface
- •Acknowledgments
- •Introduction
- •Contents
- •Contributors
- •Risk Factors
- •Prevention
- •Chemoprophylaxis
- •Preoperative Chemoprophylaxis
- •Mechanical Prophylaxis
- •Early Mobilization
- •Extended Postoperative Chemoprophylaxis
- •Prophylactic IVC Filters
- •Diagnosis
- •Imaging
- •Treatment
- •Therapeutic Anticoagulation
- •Medication Options
- •IVC Filter Placement
- •References
- •1: Perioperative Venous Thromboembolism
- •Background
- •Epidemiology
- •Preoperative Considerations
- •Intraoperative Considerations
- •Postoperative Considerations
- •Future Directions
- •Thromboembolic Events
- •Prehabilitation
- •Immunonutrition
- •Summary
- •References
- •3: Frailty
- •Frailty
- •Assessing Frailty
- •Interventions Following Frailty Assessment
- •Conclusion
- •References
- •Introduction
- •(Neo)Adjuvant Therapy
- •Conclusions
- •References
- •Background
- •Prevention
- •Recognition
- •Management
- •Background
- •Prevention
- •Recognition
- •Management
- •Uterine Perforation
- •Background
- •Prevention
- •Recognition
- •Management
- •Background
- •Prevention
- •Recognition
- •Management
- •Background
- •Prevention
- •Recognition
- •Management
- •Background
- •Prevention
- •Recognition
- •Management
- •References
- •6: Hysterectomy
- •Introduction
- •Hemorrhage
- •Background
- •Prevention
- •Recognition
- •Management
- •Bladder Injury
- •Background
- •Prevention
- •Recognition
- •Management
- •Ureteral Injury
- •Background
- •Recognition
- •Management
- •Bowel Injury
- •Background
- •Prevention
- •Recognition
- •Management
- •Background
- •Prevention
- •Recognition
- •Management
- •Urinary Tract Injury
- •Background
- •Prevention
- •Recognition
- •Management
- •Bowel Injury
- •Background
- •Prevention
- •Recognition
- •Management
- •Nerve Injury
- •Background
- •Prevention
- •Recognition
- •Management
- •Postoperative Considerations
- •Prolapse Recurrence
- •Conclusion
- •References
- •Prevention
- •Recognition
- •Management
- •References
- •7: Genital Tract Prolapse
- •Intraoperative Injuries
- •Vascular Injury
- •Background
- •Introduction
- •Injectable Therapy
- •An Overview
- •Complications
- •Retention
- •De Novo Irritative Voiding Symptoms
- •Mid-Urethral Slings (MUS)
- •An Overview
- •Tension-Free Vaginal Tape (TVT)
- •Transobturator Tape (TOT)
- •Single-Incision Slings (SIS)
- •Complications
- •Mesh Erosion
- •Bladder Injury
- •Pain
- •Voiding Dysfunction
- •De Novo Irritative Voiding Symptoms
- •Recurrent Incontinence
- •Pubovaginal Slings (PVS)
- •An Overview
- •Complications
- •Bladder Perforation
- •Urinary Retention
- •De Novo Irritative Voiding Symptoms
- •Recurrent Incontinence
- •Retropubic Suspensions
- •An Overview
- •Complications
- •Voiding Dysfunction
- •Recurrent Incontinence
- •Conclusions
- •References
- •9: Urethral Diverticulectomy
- •Diagnosis
- •Surgical Management
- •Complications Following Urethral Diverticulectomy
- •Stress Urinary Incontinence
- •De Novo SUI
- •Urethrovaginal Fistula
- •Urethral Stricture
- •Recurrent Urethral Diverticulum
- •Conclusions
- •References
- •10: Segmental or Total Female Urethrectomy
- •Meatotomy
- •Stress Urinary Incontinence (SUI) After Partial Urethrectomy
- •Pubovaginal Slings (PVSs)
- •Pubovaginal Sling Erosion
- •References
- •11: Transurethral Bladder Surgery
- •Introduction
- •Bladder Perforation
- •Cystitis: Infection/Urinary Tract Infection (UTI)
- •Summary
- •References
- •12: Partial Cystectomy
- •Introduction
- •Preoperative Workup
- •Surgical Technique
- •Complications
- •Oncological Outcomes
- •Conclusions
- •References
- •Introduction
- •Surgical Approach
- •Complications by Category
- •Genitourinary
- •Infection
- •Gastrointestinal
- •Cardiopulmonary
- •Bleeding/Thromboembolic
- •Neurological
- •Cerebrovascular Accident/Stroke
- •Delirium/Agitation
- •Miscellaneous
- •Lymphocele
- •Organ-Sparing Cystectomy (Uterus-, Fallopian Tube-, Ovary-Sparing)
- •Ovary Removal Risks (Bone Loss, Fracture Risk, Cardiac Events, Cognitive Decline, Mortality)
- •Vaginal Complications
- •References
- •14: Complications in Orthotopic Neobladders
- •Introduction
- •Early Postoperative Complications
- •Long-Term Complications
- •Conclusions
- •References
- •Introduction
- •Ileocecal Reservoirs
- •Colonic Reservoirs
- •Ileal Reservoirs
- •Conclusions
- •References
- •Introduction
- •Stoma-Related Complications
- •Parastomal Hernia
- •Stomal Stenosis
- •Ureterointestinal Stricture
- •Infection
- •Enterocutaneous Fistula
- •Anastomotic Leak
- •Conduit Necrosis
- •Metabolic Disturbances
- •Additional Thoughts
- •References
- •Background
- •Management
- •References
- •18: Ureteroscopy
- •Introduction
- •Intraoperative Complications
- •Ureteral Wall Injury
- •Background
- •Prevention
- •Recognition
- •Management
- •Background
- •Prevention
- •Recognition
- •Management
- •Bleeding
- •Background
- •Prevention
- •Management
- •Early Postoperative Complications
- •Vascular Anomalies
- •Background
- •Recognition
- •Management
- •Background
- •Prevention
- •Recognition
- •Management
- •Ureteral Stent Discomfort
- •Premature Labor
- •Ureteral Stent Migration
- •Background
- •Prevention
- •Recognition
- •Management
- •Intravascular Stent Misplacement
- •Post-Obstructive Diuresis
- •Late Postoperative Complications
- •Ureteral Strictures
- •Background
- •Prevention
- •Recognition
- •Management
- •Neglected Stents
- •Background
- •Prevention
- •Recognition
- •Management
- •Conclusions
- •References
- •Introduction
- •Perforation
- •Background
- •Prevention
- •Recognition
- •Management
- •Bleeding
- •Background
- •Prevention
- •Recognition
- •Management
- •Abscesses
- •Background
- •Prevention
- •Recognition
- •Management
- •Strictures
- •Background
- •Prevention
- •Recognition
- •Management
- •Fecal Incontinence
- •Background
- •Prevention
- •Recognition
- •Management
- •Urinary Retention
- •Background
- •Prevention
- •Recognition
- •Management
- •References
- •Cryptoglandular Pathophysiology—Abscess
- •Fistula-in-Ano
- •Fistulotomy
- •Seton Placement
- •Fistula Plugs/Fibrin Glue
- •Endorectal Advancement Flap (ERAF)
- •Minimally Invasive Approaches
- •Mesenchymal Stem Cell (MSC) Therapy
- •Complex Advanced Fistula Therapy
- •Conclusions
- •References
- •21: Fecal Incontinence
- •Treatment
- •Anal Insertion Devices
- •Vaginal Bowel Control Systems
- •Bulking Agents
- •Radio-Frequency Tissue Remodeling (SECCA®)
- •Percutaneous Tibial Nerve Stimulation (PTNS)
- •Sacral Nerve Neuromodulation (SNM)
- •Surgical Sphincter Repair (Sphincteroplasty)
- •Ventral Mesh Rectopexy (VMR)
- •Other Treatments
- •References
- •General Background
- •Preoperative Procedural Considerations
- •General Abdominal Surgery Complications
- •Hemorrhagic Complications During Rectopexy
- •Mesh Complications
- •Discitis
- •Intra-Abdominal Collections/Seromas/Abscesses
- •Ureteral Injury
- •Bowel Obstruction
- •Anastomotic Leaks
- •Postoperative Pain
- •Perineal Surgery
- •Multicompartment Prolapse Repairs
- •Postoperative Constipation/Fecal Impaction
- •Conclusions
- •References
- •Background
- •Prevention
- •Recognition
- •Vascular Injury
- •Bowel Injury
- •Management
- •Major Vascular Injury
- •Carbon Dioxide Embolism
- •Bowel Injury
- •Background
- •Recognition
- •Incision Site Hernia
- •Background
- •Recognition
- •Respiratory Mechanics
- •Preoperative Evaluation
- •Positioning
- •Trendelenburg Complications
- •Cardiopulmonary
- •Ocular Complications
- •Peripheral Nerve Injury
- •References
- •Background
- •Diagnosis
- •Treatment
- •The General Surgical Approach
- •Nerve-Sparing Surgery
- •Bladder Endometriosis
- •Diagnosis
- •Treatment
- •Ureteral Endometriosis (UE)
- •Diagnosis
- •Treatment
- •Ureteral Complications
- •Diagnosis
- •Surgical Treatment
- •Shaving Excision
- •Laparoscopic Disk Excision
- •Segmental Resection
- •Bowel Complications
- •Conclusions
- •References
- •Introduction
- •Intraoperative Complications
- •Early Postoperative Complications
- •Surgical Site Infections
- •Late Postoperative Complications
- •Anastomotic/Pouch Fistulas
- •Infertility
- •Sexual Dysfunction
- •Unhealed Perineal Wound
- •Entrapped Ovary (Inclusion Cyst)
- •Summary
- •References
- •Introduction
- •Genitourinary Complications
- •Background
- •Prevention
- •Recognition
- •Management
- •Urinary Tract
- •Background
- •Prevention
- •Recognition
- •Management
- •Bladder Injury
- •Background
- •Prevention
- •Recognition
- •Management
- •Vascular Injury
- •Background
- •Prevention
- •Recognition
- •Management
- •Neurologic Injury
- •Background
- •Prevention
- •Recognition
- •Management
- •References
- •27: Cesarean Section
- •Introduction
- •Postpartum Hemorrhage
- •Background
- •Prevention
- •Recognition
- •Management
- •Unintended Hysterotomy Extension
- •Background
- •Prevention
- •Recognition
- •Management
- •Uterine Scar Dehiscence
- •Background
- •Prevention
- •Recognition
- •Management
- •Uterine Inversion
- •Background
- •Prevention
- •Recognition
- •Management
- •Background
- •Prevention
- •Recognition
- •Management
- •Post-Cesarean Infection
- •Background
- •Prevention
- •Recognition
- •Management
- •References
- •28: Management of Ectopic Pregnancy and Surgical Considerations
- •Background
- •Tubal Ectopic Pregnancy
- •Prevention
- •Laparoscopy Versus Laparotomy
- •Recognition
- •Massive Hemorrhage, Hemodynamic Instability
- •Nondiagnostic Laparoscopy
- •Management
- •Hemoperitoneum
- •Nontubal Ectopic Pregnancy
- •Prevention
- •Recognition
- •Management
- •Interstitial
- •Ovarian
- •References
- •29: Surgical Abortion
- •Introduction
- •Hemorrhage
- •Uterine Atony
- •Background
- •Prevention
- •Recognition
- •Management
- •Abnormal Placentation
- •Background
- •Prevention
- •Acute Coagulopathy
- •Background
- •Prevention
- •Recognition
- •Management
- •Cervical Injury
- •Background
- •Prevention
- •Recognition
- •Management
- •Uterine Injury
- •Background
- •Prevention
- •Recognition
- •Management
- •Infection
- •Background
- •Prevention
- •Recognition
- •Management
- •Background
- •Prevention
- •Conclusions
- •References
- •30: Cesarean Hysterectomy
- •Introduction
- •Obstetric Hemorrhage
- •Background
- •Prevention
- •Recognition
- •Management
- •Surgical Site Infection
- •Background
- •Prevention
- •Recognition
- •Management
- •Massive Obstetric Hemorrhage
- •Background
- •Prevention
- •Recognition
- •Management
- •Disseminated Intravascular Coagulopathy (DIC)
- •Background
- •Prevention
- •Recognition
- •Management
- •Urologic Injury
- •Background
- •Prevention
- •Recognition
- •Management
- •References
- •31: Inguinal Lymphadenectomy, Radical Vulvectomy
- •References
- •Introduction
- •Vascular Injury
- •Background
- •Prevention
- •Recognition
- •Management
- •Lymphedema
- •Background
- •Prevention
- •Recognition
- •Management
- •Nerve Injury
- •Background
- •Prevention
- •Recognition
- •Management
- •Ureteral Injury
- •Background
- •Prevention
- •Recognition
- •Management
- •Background
- •Prevention
- •Recognition
- •Management
- •Duodenum
- •Background
- •Prevention
- •Recognition
- •Management
- •Arterial Embolization
- •Background
- •Prevention
- •Recognition
- •Management
- •Background
- •Prevention
- •Management
- •References
- •33: Radical Hysterectomy
- •Introduction
- •Ureteral Injury
- •Background
- •Prevention
- •Recognition
- •Management
- •Bladder Injury
- •Background
- •Prevention
- •Recognition
- •Management
- •Rectal Injury
- •Background
- •Prevention
- •Recognition
- •Management
- •Bladder Dysfunction
- •Background
- •Prevention
- •Recognition
- •Management
- •Colorectal Dysfunction
- •Background
- •Prevention
- •Recognition
- •Management
- •Surgical Site Infection
- •Background
- •Prevention
- •Recognition
- •Management
- •Sexual Dysfunction
- •Background
- •Prevention
- •Recognition
- •Management
- •References
- •Vascular Injury
- •Background
- •Prevention
- •Recognition
- •Management
- •Post-Operative Bleeding/Hematoma
- •Background
- •Prevention
- •Recognition
- •Management
- •Urinary Tract Injury
- •Background
- •Prevention
- •Recognition
- •Management
- •Anastomotic Leak
- •Background
- •Prevention
- •Recognition
- •Management
- •Bowel Injury
- •Background
- •Prevention
- •Recognition
- •Management
- •Anastomotic Bleeding
- •Background
- •Prevention
- •Recognition
- •Management
- •Anastomotic Stricture
- •Background
- •Prevention
- •Recognition
- •Management
- •References
- •35: Anal Cancer
- •Introduction
- •Perineal Wound Infection/Dehiscence
- •Background
- •Prevention
- •Recognition
- •Management
- •Acute
- •Chronic
- •Pelvic Fluid Collections/Abscesses/Organ Space Infections
- •Background
- •Prevention
- •Recognition
- •Management
- •Perineal Hernia
- •Background
- •Prevention
- •Recognition
- •Management
- •Small Bowel Obstruction
- •Background
- •Prevention
- •Recognition
- •Management
- •Large Bowel Obstruction
- •Background
- •Prevention
- •Recognition
- •Management
- •Fecal Incontinence
- •Background
- •Prevention
- •Recognition
- •Management
- •Rectovaginal Fistula
- •Background
- •Prevention
- •Recognition
- •Management
- •Radiation Enteritis
- •Background
- •Prevention
- •Recognition
- •Management
- •Sigmoid Stricture Formation
- •Background
- •Prevention
- •Recognition
- •Management
- •Conclusion
- •References
- •Introduction
- •Anastomotic Leak
- •Background
- •Prevention
- •Recognition
- •Management
- •AL Requiring Operative Intervention
- •Endosponge
- •Local Repairs
- •Anastomotic Stricture
- •Background
- •Prevention
- •Recognition
- •Management
- •Anastomotic Bleeding
- •Background
- •Prevention
- •Recognition
- •Management
- •Presacral Venous Bleeding
- •Background
- •Recognition
- •Prevention
- •Management
- •Low Anterior Resection Syndrome
- •Background
- •Prevention
- •Recognition
- •Management
- •Background
- •Prevention
- •Recognition
- •Treatment
- •References
- •37: Pelvic Radiation Therapy
- •Introduction
- •External Beam Radiation Therapy
- •Brachytherapy
- •Radiotherapy Toxicity
- •Toxicities by System
- •Bladder/Ureters/Urethra
- •Background
- •Prevention
- •Recognition
- •Management
- •Small Bowel
- •Background
- •Prevention
- •Recognition
- •Management
- •Colon/Rectum
- •Background
- •Prevention
- •Recognition
- •Management
- •Anus/Vulva/Skin
- •Background
- •Prevention
- •Recognition
- •Management
- •Uterus
- •Background
- •Prevention
- •Recognition
- •Management
- •Ovaries
- •Background
- •Prevention
- •Recognition
- •Management
- •Vagina
- •Background
- •Prevention
- •Recognition
- •Management
- •Vascular/Lymphatics/Nerves
- •Background
- •Prevention
- •Recognition
- •Management
- •References
- •38: Pelvic Exenteration for Central Pelvic Cancer
- •Introduction
- •Pre-Operative Considerations
- •Intra-Operative Complications
- •WHO Checklist
- •Post-Operative Complications
- •Immediate
- •Conclusion
- •References
- •Introduction
- •Background
- •Prevention
- •Recognition
- •Management
- •Background
- •Prevention
- •Recognition
- •Management
- •Background
- •Prevention
- •Recognition
- •Management
- •Background
- •Prevention
- •Recognition
- •Management
- •Summary
- •References
- •Nerve Injury
- •Background
- •Prevention
- •Recognition
- •Management
- •Vascular Injury
- •Background
- •Prevention
- •Recognition
- •Management
- •Background
- •Prevention
- •Recognition
- •Management
- •Background
- •Prevention
- •Recognition
- •Management
- •Hardware Failure/Mechanical Complications
- •Background
- •Prevention
- •Recognition
- •Management
- •Pelvic Cancer Complications Involving Bone
- •Osteomyelitis
- •Background
- •Prevention
- •Recognition
- •Management
- •Radiation Osteitis
- •Background
- •Prevention
- •Recognition
- •Management
- •Radiation Associated Sarcomas
- •Background
- •Prevention
- •Recognition
- •Management
- •Wound Healing Considerations
- •Background
- •Prevention
- •Recognition
- •Management
- •References
- •41: Pelvic Reconstructive Procedures
- •Background
- •Prevention
- •Preoperative
- •Intraoperative
- •Postoperative
- •Recognition
- •Fluid Collection
- •Infection
- •Partial or Total Flap Loss
- •Fistula
- •Donor Site Complications
- •Management
- •Fluid Collection
- •Infection
- •Partial or Total Flap Loss
- •Fistula
- •Donor Site Complications
- •Conclusion
- •References
- •Index

4 Nutrition fortheSurgical Patient
35
tion was 18.8% and 7.9%, respectively, in gynecological cancer patients during chemotherapy
[49].
Radiation therapy is an important adjuvant in
pelvic malignancy but one with signicant nutritional morbidity. Up to 90% of patients develop a
permanent change in their bowel habits after
radiation [2]. Intestinal inammation, oxidative
stress, tissue damage, and edema lead to pain and
functional changes that restrict dietary intake.
Functional short bowel syndrome as a cause of
protein-calorie malnutrition and micronutrient
deciencies is seen in chronic radiation enteritis
[53]. Prior to starting pelvic radiation, up to 32%
of patients have lost >5% of body weight suggesting high risk for malnutrition [36]. In the
case of locally advanced rectal cancer requiring
neoadjuvant therapy and proctectomy, neoadjuvant therapy contributes to preoperative malnutrition. A retrospective study of 49 patients with
locally advanced rectal cancer in Japan identied
malnutrition in 29% of patients at the time of surgery following chemoradiation [56].
Perioperative Nutrition andtheGut
Microbiome
Particularly for cancer patients, the perioperative
course of care has become increasingly protracted and complex with rounds of multimodality therapy. Patients undergoing colorectal
resections endure periods of prolonged fasting
and mechanical bowel preparation in the weeks
before surgery, followed by IV and enteral antibiotics. While it decreases overall rates of surgical
site infections, this course of events has been
demonstrated to cause a profound and durable
dysbiosis of the colonic microbiome [30].
Surgically induced dysbiosis is exacerbated by
preexisting malnutrition [18]. Preoperative diet
and the presence of dysbiosis are both mechanistically linked to complications such as anastomotic leak and surgical site infection [50]. Recent
translational work suggests that the immune tolerance induced by diet-induced dysbiosis may
permit the recurrence of gastrointestinal cancer
[5, 55]. Cutaneous oncologists are leading the
way in reducing antibiotic exposure in cancer
patients out of concern for the negative impact of
dysbiosis on cancer outcomes [7]. Multiple fecal
microbial biomarkers are candidates for a targeted preoperative nutritional intervention
designed to mitigate specic downstream effects
of poor caloric intake [27]. Further translational
work is necessary to determine whether the above
ndings apply to gastrointestinal and genitourinary pelvic surgery.
Potential Solutions: Evidence
forMitigation ofPerioperative
Malnutrition
Preoperative nutritional counseling in high-risk
populations has been demonstrated to improve
surgical outcomes in pelvic surgery patients.
Generally, nutritional counseling has been
employed in the trial setting as part of a preoperative bundle or pathway, so while its effect has not
been isolated, strong evidence from randomized
trials of bundles containing it supports its use
[19]. Such sessions are generally performed by a
multidisciplinary team of physicians and dieticians in the preoperative clinic.
Oral protein-calorie supplementation in the
preoperative setting has demonstrated mixed
results. Nonselective supplementation for the
most part has not demonstrated a benet on postoperative outcomes. However, in patients preoperatively identied as malnourished,
supplementation with 250 mL daily proteindense shakes reduced rates of surgical site infection compared to dietary counseling alone in a
randomized controlled trial [6]. Protein-dense
oral nutritional supplementation during postoperative chemotherapy decreased malnutrition
observed in patients after cytoreductive surgery
for ovarian cancer [46]. The effects of specialized
immunonutrition supplements are mixed based
on recent meta-analyses, and no conclusive recommendations can be made at this time.
Preoperative probiotics, mostly cultures of
Lactobacillus and Bidobacterium, have shown
promise in randomized trials in preventing surgical site infection and reducing length of stay [9].

36
R. A. Jacobson et al.
An extensive and well-written review recently
summarized available data on preoperative nutritional optimization for the cancer patient [5].
Postoperative patients, as a rule, benet from
feeding the gut as soon as safely feasible and parenteral nutrition used only when enteral nutrition
is expected to be delayed for long periods. A
recent trial randomized 87 patients with nasogastric tubes and continuous parenteral nutrition
after pelvic exenteration to early trophic feeding
versus standard of care suction. The results demonstrated that the incidence of postoperative ileus
was signicantly lower in participants who were
enterally fed. Furthermore, regression analysis
showed that the longer patients were restricted
from an oral diet after surgery, the greater the
time was to rst bowel movement and the greater
the postoperative complication rates [25]. In
2013, Roth etal. conducted a clinical trial with
patients undergoing radical cystectomy/urinary
detour procedures comparing two groups: rst
group had parenteral nutrition and oral supplements during the rst ve postoperative days and
the other had only oral nutritional supplements.
The rst cohort was associated with more complications in general and infectious complications, adding to the wealth of data that supports
parenteral nutrition only being used in cases of
expected prolonged inadequate enteral nutrition
[48]. There are occasions when the timing of surgery cannot be delayed, however. In instances of
surgery on patients with or at high risk for malnutrition, consideration of early initiation of parenteral nutritional is justied. In a recent study of
patients undergoing abdominal surgery, initiation
of TPN at day 3 reduced infectious complications
compared to initiation on day 8 [57].
Conclusions
Malnutrition is a signicant modiable risk factor in pelvic surgery across specialties. Patients
and providers stand to gain from low-cost perioperative interventions that could improve surgical
outcomes. Current data support the following
practices: (1) Malnutrition needs to be recognized and measured in all patients prior to pelvic
surgery using validated risk stratication tools.
(2) If indicated, nutritional and physical prehabilitation should be implemented before surgery
in a way that ts patients’ means and abilities. (3)
All patients should initiate enteral nutrition as
early as possible in the postoperative period, with
protein-calorie supplementation where needed.
(4) Parenteral nutrition should be promptly initiated only in patients unable to receive adequate
energy through the gut. Further study is required
to use preoperative nutritional intervention, perhaps with prebiotics, to build resilience in the gut
microbiome and prevent its attendant complications. Barriers to improving perioperative nutrition practices stem principally from poor transfer
of information from the appropriate providers to
patients during the perioperative period. Buy-in
to dietary education from patients and multidisciplinary teams of providers is essential to improve
surgical outcomes in the future.
References
1. Anthony PS. Nutrition screening tools for hospitalized patients. Nutr Clin Pract. 2008;23(4):373–82.
https://doi.org/10.1177/0884533608321130.
2. Araujo IK, Munoz-Guglielmetti D, Molla
M. Radiation-induced damage in the lower gastrointestinal tract: clinical presentation, diagnostic tests and treatment options. Best Pract Res Clin
Gastroenterol. 2020;48-49:101707. https://doi.
org/10.1016/j.bpg.2020.101707.
3. Asteria CR, Gagliardi G, Pucciarelli S, Romano G,
Infantino A, La Torre F, Tonelli F, Martin F, Pulica
C, Ripetti V, Diana G, Amicucci G, Carlini M,
Sommariva A, Vinciguerra G, Poddie DB, Amato A,
Bassi R, Galleano R, Veronese E, Mancini S, Pescio
G, Occelli GL, Bracchitta S, Castagnola M, Pontillo
T, Cimmino G, Prati U, Vincenti R.Anastomotic leaks
after anterior resection for mid and low rectal cancer:
survey of the Italian Society of Colorectal Surgery.
Tech Coloproctol. 2008;12(2):103–10. https://doi.
org/10.1007/s10151- 008- 0407- 9.
4. Bernstein LH, Leukhardt-Faireld CJ, Pleban W,
Rudolph R.Usefulness of data on albumin and prealbumin concentrations in determining effectiveness
of nutritional support. Clin Chem. 1989;35(2):271–4.
5. Brajcich BC, Stigall K, Walsh DS, Varghese TK,
Barber AE, Kralovich KA, Wescott AB, Pockaj BA,
Ko CY, Laronga C. Preoperative nutritional optimization of the oncology patient: a scoping review.
J Am Coll Surg. 2022;234(3):384–94. https://doi.
org/10.1097/XCS.0000000000000055.

4 Nutrition fortheSurgical Patient
37
6. Burden ST, Gibson DJ, Lal S, Hill J, Pilling M, Soop
M, Ramesh A, Todd C.Pre-operative oral nutritional
supplementation with dietary advice versus dietary
advice alone in weight-losing patients with colorectal cancer: single-blind randomized controlled trial.
J Cachexia Sarcopenia Muscle. 2017;8(3):437–46.
https://doi.org/10.1002/jcsm.12170.
7. Cass RGW, Meng X, Sahasrabhojane P, Bassett RL,
Shelburne S, Chang HY, Somaiya K, Mungovan K,
Fisher SB, Lucci A, Lee JE, Ross MI, Gershenwald
JE, Duncan S, Ajami NJ, Roland CL, Wargo JA,
Keung EZ-Y. Evaluating the impact of perioperative
antibiotic prophylaxis on the microbiome in patients
with cutaneous malignancy. Abstract presented at
JCO.J Clin Oncol. 2022;40(16 suppl):TPS9602.
8. Cederholm T, Jensen GL, Correia M, Gonzalez MC,
Fukushima R, Higashiguchi T, Baptista G, Barazzoni
R, Blaauw R, Coats AJS, Crivelli AN, Evans DC,
Gramlich L, Fuchs-Tarlovsky V, Keller H, Llido L,
Malone A, Mogensen KM, Morley JE, Muscaritoli
M, Nyulasi I, Pirlich M, Pisprasert V, de van der
Schueren MAE, Siltharm S, Singer P, Tappenden
K, Velasco N, Waitzberg D, Yamwong P, Yu J, Van
Gossum A, Compher C, Glim Core Leadership
Committee GWG. GLIM criteria for the diagnosis
of malnutrition—a consensus report from the global
clinical nutrition community. J Cachexia Sarcopenia
Muscle. 2019;10(1):207–17. https://doi.org/10.1002/
jcsm.12383.
9. Chowdhury AH, Adiamah A, Kushairi A, Varadhan
KK, Krznaric Z, Kulkarni AD, Neal KR, Lobo
DN. Perioperative probiotics or Synbiotics in adults
undergoing elective abdominal surgery: a systematic
review and meta-analysis of randomized controlled
trials. Ann Surg. 2020;271(6):1036–47. https://doi.
org/10.1097/SLA.0000000000003581.
10. Coda A, Bossotti M, Ferri F, Mattio R, Ramellini G,
Poma A, Quaglino F, Filippa C, Bona A. Incisional
hernia and fascial defect following laparoscopic
surgery. Surg Laparosc Endosc Percutan Tech.
2000;10(1):34–8.
11. Curran T. Perioperative nutritional considerations in colon and Rectal surgery. Clin Colon
Rectal Surg. 2023;36(3):192–7. https://doi.
org/10.1055/s- 0043- 1761152.
12. Davis CJ, Sowa D, Keim KS, Kinnare K,
Peterson S. The use of prealbumin and
C-reactive protein for monitoring nutrition support in adult patients receiving enteral nutrition in an urban medical center. JPEN J Parenter
Enteral Nutr. 2012;36(2):197–204. https://doi.
org/10.1177/0148607111413896.
13. de Oliveira AL, Boroni Moreira AP, Pereira Netto M,
Goncalves Leite IC.A cross-sectional study of nutritional status, diet, and dietary restrictions among persons with an ileostomy or colostomy. Ostomy Wound
Manage. 2018;64(5):18–29.
14. Detsky AS, McLaughlin JR, Baker JP, Johnston
N, Whittaker S, Mendelson RA, Jeejeebhoy
KN. What is subjective global assess-
ment of nutritional status? JPEN J Parenter
Enteral Nutr. 1987;11(1):8–13. https://doi.
org/10.1177/014860718701100108.
15. Duerksen DR, Laporte M, Jeejeebhoy K.Evaluation
of nutrition status using the subjective global assessment: malnutrition, cachexia, and sarcopenia.
Nutr Clin Pract. 2021;36(5):942–56. https://doi.
org/10.1002/ncp.10613.
16. Fazzini B, Markl T, Costas C, Blobner M, Schaller
SJ, Prowle J, Puthucheary Z, Wackerhage H. The
rate and assessment of muscle wasting during critical illness: a systematic review and meta-analysis.
Crit Care. 2023;27(1):2. https://doi.org/10.1186/
s13054- 022- 04253- 0.
17. Fleck A.Clinical and nutritional aspects of changes in
acute-phase proteins during inammation. Proc Nutr
Soc. 1989;48(3):347–54. https://doi.org/10.1079/
pns19890050.
18. Gaines S, van Praagh JB, Williamson AJ, Jacobson
RA, Hyoju S, Zaborin A, Mao J, Koo HY, Alpert L,
Bissonnette M, Weichselbaum R, Gilbert J, Chang
E, Hyman N, Zaborina O, Shogan BD, Alverdy
JC.Western diet promotes intestinal colonization by
Collagenolytic microbes and promotes tumor formation after colorectal surgery. Gastroenterology.
2020;158(4):958–970 e952. https://doi.org/10.1053/j.
gastro.2019.10.020.
19. Gillis C, Buhler K, Bresee L, Carli F, Gramlich L,
Culos-Reed N, Sajobi TT, Fenton TR. Effects of
nutritional prehabilitation, with and without exercise, on outcomes of patients who undergo colorectal surgery: a systematic review and meta-analysis.
Gastroenterology. 2018;155(2):391–410 e394. https://
doi.org/10.1053/j.gastro.2018.05.012.
20. Grace E, Shaw C, Whelan K, Andreyev HJ.Review
article: small intestinal bacterial overgrowth—prevalence, clinical features, current and developing
diagnostic tests, and treatment. Aliment Pharmacol
Ther. 2013;38(7):674–88. https://doi.org/10.1111/
apt.12456.
21. Guigoz Y, Vellas B.The mini nutritional assessment
(MNA) for grading the nutritional state of elderly
patients: presentation of the MNA, history and validation. Nestle Nutr Workshop Ser Clin Perform
Programme. 1999;1:3–11.; discussion 11–12. https://
doi.org/10.1159/000062967.
22. Guigoz Y, Vellas B. Nutritional assessment in older
adults : MNA(R) 25 years of a screening tool and a
reference standard for care and research; what next?
J Nutr Health Aging. 2021;25(4):528–83. https://doi.
org/10.1007/s12603- 021- 1601- y.
23. Heper Y, Akalin EH, Mistik R, Akgoz S, Tore O,
Goral G, Oral B, Budak F, Helvaci S. Evaluation
of serum C-reactive protein, procalcitonin, tumor
necrosis factor alpha, and interleukin-10 levels as
diagnostic and prognostic parameters in patients
with community- acquired sepsis, severe sepsis, and septic shock. Eur J Clin Microbiol Infect
Dis. 2006;25(8):481–91. https://doi.org/10.1007/
s10096- 006- 0168- 1.

38
R. A. Jacobson et al.
24. Heyland DK, Dhaliwal R, Jiang X, Day
AG. Identifying critically ill patients who benet
the most from nutrition therapy: the development
and initial validation of a novel risk assessment tool.
Crit Care. 2011;15(6):R268. https://doi.org/10.1186/
cc10546.
25. Hogan S, Reece L, Solomon M, Rangan A, Carey
S. Early enteral feeding is benecial for patients
after pelvic exenteration surgery: a randomized
controlled trial. JPEN J Parenter Enteral Nutr.
2022;46(2):411–21. https://doi.org/10.1002/
jpen.2120.
26. Jones KI, Doleman B, Scott S, Lund JN, Williams
JP. Simple psoas cross-sectional area measurement
is a quick and easy method to assess sarcopenia
and predicts major surgical complications. Color
Dis. 2015;17(1):O20–6. https://doi.org/10.1111/
codi.12805.
27. Jonkers DM. Microbial perturbations and modulation in conditions associated with malnutrition and
malabsorption. Best Pract Res Clin Gastroenterol.
2016;30(2):161–72. https://doi.org/10.1016/j.
bpg.2016.02.006.
28. Kathiresan AS, Brookeld KF, Schuman SI, Lucci
JA 3rd. Malnutrition as a predictor of poor postoperative outcomes in gynecologic cancer patients. Arch
Gynecol Obstet. 2011;284(2):445–51. https://doi.
org/10.1007/s00404- 010- 1659- y.
29. Kondrup J. Nutritional-risk scoring systems in the
intensive care unit. Curr Opin Clin Nutr Metab
Care. 2014;17(2):177–82. https://doi.org/10.1097/
MCO.0000000000000041.
30. Krezalek MA, Alverdy JC.The role of the microbiota in surgical recovery. Curr Opin Clin Nutr Metab
Care. 2016;19(5):347–52. https://doi.org/10.1097/
MCO.0000000000000299.
31. Lanctin DP, Merced-Nieves F, Mallett RM, Arensberg
MB, Guenter P, Sulo S, Platts-Mills TF.Prevalence
and economic Burden of malnutrition diagnosis
among patients presenting to United States Emergency
Departments. Acad Emerg Med. 2021;28(3):325–35.
https://doi.org/10.1111/acem.13887.
32. Lee DU, Fan GH, Hastie DJ, Addonizio EA, Suh J,
Prakasam VN, Karagozian R. The clinical impact
of malnutrition on the postoperative outcomes
of patients undergoing colorectal resection surgery for colon or rectal cancer: propensity score
matched analysis of 2011–2017 US hospitals. Surg
Oncol. 2021;38:101587. https://doi.org/10.1016/j.
suronc.2021.101587.
33. Lin J, Peng J, Qdaisat A, Li L, Chen G, Lu Z, Wu
X, Gao Y, Zeng Z, Ding P, Pan Z. Severe weight
loss during preoperative chemoradiotherapy compromises survival outcome for patients with locally
advanced rectal cancer. J Cancer Res Clin Oncol.
2016;142(12):2551–60. https://doi.org/10.1007/
s00432- 016- 2225- 1.
34. Makela JT, Kiviniemi H, Juvonen T, Laitinen
S. Factors inuencing wound dehiscence after mid-
line laparotomy. Am J Surg. 1995;170(4):387–90.
https://doi.org/10.1016/s0002- 9610(99)80309- 2.
35. McClave SA, DiBaise JK, Mullin GE, Martindale
RG. ACG clinical guideline: nutrition therapy in
the adult hospitalized patient. Am J Gastroenterol.
2016;111(3):315–34.; quiz 335. https://doi.
org/10.1038/ajg.2016.28.
36. McGough C, Baldwin C, Frost G, Andreyev HJ.Role
of nutritional intervention in patients treated with
radiotherapy for pelvic malignancy. Br J Cancer.
2004;90(12):2278–87. https://doi.org/10.1038/
sj.bjc.6601868.
37. McKenna NP, Bews KA, Al-Refaie WB, Colibaseanu
DT, Pemberton JH, Cima RR, Habermann
EB. Assessing malnutrition before major oncologic
surgery: one size does not t all. J Am Coll Surg.
2020;230(4):451–60. https://doi.org/10.1016/j.
jamcollsurg.2019.12.034.
38. Moraes JT, Melo AFF, Araujo C, Faria R, Ferreira
NR, Belo VS. Anthropometric and dietetic evaluation of people with ileostomies. Arq Gastroenterol.
2019;56(1):34–40. https://doi.org/10.1590/
S0004- 2803.201900000- 07.
39. Nakayama M, Yoshimatsu K, Yokomizo H, Yano Y,
Okayama S, Satake M, Matsumoto A, Fujimoto T,
Usui T, Yamaguchi K, Shiozawa S, Shimakawa T,
Katsube T, Naritaka Y. Incidence and risk factors for
incisional hernia after open surgery for colorectal cancer. Hepato-Gastroenterology. 2014;61(133):1220–3.
40. Ornaghi PI, Afferi L, Antonelli A, Cerruto MA,
Odorizzi K, Gozzo A, Mordasini L, Mattei A,
Baumeister P, Cornelius J, Tafuri A, Moschini
M. The impact of preoperative nutritional status on
post-surgical complication and mortality rates in
patients undergoing radical cystectomy for bladder
cancer: a systematic review of the literature. World
J Urol. 2021;39(4):1045–81. https://doi.org/10.1007/
s00345- 020- 03291- z.
41. Ottery FD. Bidirectional interplay of nutrition and
chemotherapy. Nestle Nutr Workshop Ser Clin
Perform Programme. 2000;4:183–202.; discussion
203–186. https://doi.org/10.1159/000061815.
42. Paur I, Smedshaug GB, Haugum B, Bye A, Eliassen
E, Flottorp TL, Juul HJ, Mowe M, Nakken T, Ore
S, Sirevag GK, Sygnestveit K, Thoresen L, Aasen
EB, Totland TH, Krogh HW. The Norwegian
Directorate of Health recommends malnutrition screening tool (MST) for all adults. Clin Nutr
ESPEN. 2022;52:28–31. https://doi.org/10.1016/j.
clnesp.2022.09.029.
43. Portuondo JI, Probstfeld L, Massarweh NN, Le
L, Wei Q, Chai CY, Taylor J, Awad SS, Tran Cao
HS. Malnutrition in elective surgery: how traditional markers might be failing surgeons and
patients. Surgery. 2020;168(6):1144–51. https://doi.
org/10.1016/j.surg.2020.08.012.
44. Pressoir M, Desné S, Berchery D, Rossignol G,
Poiree B, Meslier M, Traversier S, Vittot M, Simon M,
Gekiere JP, Meuric J, Serot F, Falewee MN, Rodrigues
I, Senesse P, Vasson MP, Chelle F, Maget B, Antoun

4 Nutrition fortheSurgical Patient
39
S, Bachmann P.Prevalence, risk factors and clinical
implications of malnutrition in French comprehensive
cancer Centres. Br J Cancer. 2010;102(6):966–71.
https://doi.org/10.1038/sj.bjc.6605578.
45. Puthucheary ZA, McNelly AS, Rawal J, Connolly B,
Sidhu PS, Rowlerson A, Moxham J, Harridge SD,
Hart N, Montgomery HE. Rectus Femoris crosssectional area and muscle layer thickness: comparative markers of muscle wasting and weakness. Am
J Respir Crit Care Med. 2017;195(1):136–8. https://
doi.org/10.1164/rccm.201604- 0875LE.
46. Qin N, Jiang G, Zhang X, Sun D, Liu M.The effect
of nutrition intervention with oral nutritional supplements on ovarian cancer patients undergoing chemotherapy. Front Nutr. 2021;8:685967. https://doi.
org/10.3389/fnut.2021.685967.
47. Quigley EMM, Murray JA, Pimentel M. AGA
clinical practice update on small intestinal bacterial overgrowth: expert review. Gastroenterology.
2020;159(4):1526–32. https://doi.org/10.1053/j.
gastro.2020.06.090.
48. Roth B, Birkhauser FD, Zehnder P, Thalmann GN,
Huwyler M, Burkhard FC, Studer UE. Parenteral
nutrition does not improve postoperative recovery
from radical cystectomy: results of a prospective randomised trial. Eur Urol. 2013;63(3):475–82. https://
doi.org/10.1016/j.eururo.2012.05.052.
49. Sanguanwongthong K, Suprasert P. Prevalence of
malnourishment and predictive factors associated
with the nutritional status of gynecologic cancer
patients undergoing chemotherapy: a cross-sectional
analysis. Obstet Gynecol Sci. 2022;65(3):234–43.
https://doi.org/10.5468/ogs.21298.
50. Shogan BD, Belogortseva N, Luong PM, Zaborin A,
Lax S, Bethel C, Ward M, Muldoon JP, Singer M, An G,
Umanskiy K, Konda V, Shakhsheer B, Luo J, Klabbers
R, Hancock LE, Gilbert J, Zaborina O, Alverdy
JC. Collagen degradation and MMP9 activation by
enterococcus faecalis contribute to intestinal anastomotic leak. Sci Transl Med. 2015;7(286):286ra268.
https://doi.org/10.1126/scitranslmed.3010658.
51. Soloff MA, Vargas MV, Wei C, Ohnona A, Tyan P,
Gu A, Georgakopoulos B, Thomas CA, Quan T,
Barishansky S, Moawad G.Malnutrition is associated
with poor postoperative outcomes following laparoscopic hysterectomy. JSLS. 2021;25(1):e2020.00084.
https://doi.org/10.4293/JSLS.2020.00084.
52. Thurnham DI. Interactions between nutrition and
immune function: using inammation biomarkers to interpret micronutrient status. Proc Nutr
Soc. 2014;73(1):1–8. https://doi.org/10.1017/
S0029665113003662.
53. Webb GJ, Brooke R, De Silva AN. Chronic
radiation enteritis and malnutrition. J
Dig Dis. 2013;14(7):350–7. https://doi.
org/10.1111/1751- 2980.12061.
54. White JV, Guenter P, Jensen G, Malone A,
Schoeld M. Consensus statement: academy
of nutrition and dietetics and American Society
for Parenteral and Enteral Nutrition. J Parenter
Enter Nutr. 2012;36(3):275–83. https://doi.
org/10.1177/0148607112440285.
55. Williamson AJ, Jacobson R, van Praagh JB, Gaines S,
Koo HY, Lee B, Chan WC, Weichselbaum R, Alverdy
JC, Zaborina O, Shogan BD. Enterococcus faecalis
promotes a migratory and invasive phenotype in colon
cancer cells. Neoplasia. 2022;27:100787. https://doi.
org/10.1016/j.neo.2022.100787.
56. Yamano T, Yoshimura M, Kobayashi M, Beppu N,
Hamanaka M, Babaya A, Tsukamoto K, Noda M,
Matsubara N, Tomita N. Malnutrition in rectal cancer patients receiving preoperative chemoradiotherapy is common and associated with treatment
tolerability and anastomotic leakage. Int J Color
Dis. 2016;31(4):877–84. https://doi.org/10.1007/
s00384- 016- 2507- 8.
57. Zhu Z, Gao Z, Li K.Supplemental parenteral nutrition in patients undergoing abdominal surgery. JAMA
Surg. 2022;157(10):966–7. https://doi.org/10.1001/
jamasurg.2022.2654.

Uterine Surgery forInfertility
JensenReckhow andZaraqKhan
5
Bleeding andNeed
forHysterectomy
Background
Bleeding is one of the most signicant risks of
uterine surgery, as the uterus has a rich blood
supply and uterine-sparing surgeries are often
complex. Blood loss is of particular concern in
more complex surgeries such as myomectomy,
adenomyomectomy, and excision of deep inltrating endometriosis, and excessive blood loss
increases the risk of surgical site infection, transfusion, and reoperation [1]. Furthermore, signicant blood loss at the time of myomectomy
increases the risk for hysterectomy [2–5]. While
there is currently no data on the risk of hysterectomy at the time of adenomyomectomy, this is
likely to be a considerable risk as these procedures are technically challenging.
Bleeding is also the most common complication after transvaginal ultrasound-guided oocyte
retrieval—the most frequently performed procedure by reproductive endocrinologists.
J. Reckhow
Department of Obstetrics and Gynecology,
Mayo Clinic, Rochester, MN, USA
e-mail: reckhow.jensen@mayo.edu
Z. Khan (*)
Division Chair for Reproductive Endocrinology
and Infertility, Mayo Clinic, Rochester, MN, USA
e-mail: khan.zaraq@mayo.edu
Prevention
Medical optimization prior to surgery reduces
complications. Preoperative anemia should be
identied; pretreatment with oral or intravenous
iron supplementation may reduce transfusion risk
for patients undergoing procedures with a high
anticipated blood loss [1]. Preoperative treatment
with gonadotropin releasing hormone (GnRH)
analogs should be considered in patients with
leiomyomas or adenomyosis, as treatment can
reduce uterine size and thereby help decrease
intraoperative blood loss [6, 7]. Cumulative surgical complication risk is lower with laparoscopic
myomectomy than open myomectomy and is
notably associated with a vefold reduction in
blood transfusion risk [1, 8]. While the risk of
any complication is currently lower with laparoscopic approach as compared to robotic approach,
this difference is likely to be mitigated as robotic
training becomes more widespread [9].
Minimizing intraoperative blood loss
improves visualization and reduces risk of other
surgical complications. When performing myomectomy through any approach, vasopressin
injected into the cervix as well as the broids
themselves helps reduce blood ow to the surgical eld [10–12]. Transient occlusion of the
uterine arteries (TOUA) and use of a uterine
tourniquet have been shown to decrease blood
loss during adenomyomectomy (Figs.5.1 and
5.2) [13]. Preoperative administration of miso-
© The Author(s), under exclusive license to Springer Nature Switzerland AG 2025
M. Hoffman et al. (eds.), Major Complications of Female Pelvic Surgery,
https://doi.org/10.1007/978-3-031-66772-5_5
43

44
Uterus
Ut
Uterus
niquet
J. Reckhow and Z. Khan
erine artery
Leiomyoma
Fig. 5.1 A Bulldog clamp may be used to temporarily occlude the uterine vessels, decreasing the pulse pressure of
blood ow to the uterus
Broad
ligament
Uterine artery
Tour
Fig. 5.2 A Penrose drain may be placed circumferentially around the cervix, passing it through the broad ligament on
either side, to temporarily occlude the uterine vessels during uterine surgery

ab
cd
5 Uterine Surgery forInfertility
45
Fig. 5.3 (a–d) During transvaginal oocyte retrieval, sig-
nicant hemorrhage can occur if the iliac vessels are mistakenly entered. (a) and (b) (without and with color
doppler ow) show ovarian follicles in close proximity to
the iliac vessels. In this plane, the vessels are readily distinguished from the follicles by shape. (c) and (d) (with-
prostol reduces blood ow to the uterus and may
out and with color doppler ow) show the same follicles
and the iliac vessels in cross section. In this view, the vessels may be mistaken for follicles. It is essential to note
the difference in echogenicity between the follicles and
the vessels, as this may be the main distinguishing feature
between the two
Recognition
decrease blood loss for any uterine surgery [6].
Prophylactic administration of tranexamic acid is
also associated with decreased intraoperative
blood loss [13]. Intraoperative blood salvage is
not recommended for routine use but may
decrease the risk of blood transfusion in appropriately selected patients with a high burden of
disease and when a prolonged, complex surgery
is anticipated [14, 15].
Ultrasound guidance during oocyte retrieval
allows the operator to stay clear of the iliac vessels upon which a stimulated ovary typically
rests. In a certain plane, these large iliac vessels
can be confused with a follicle. Closely watching
for vessel movement with pulsation and turning
the ultrasound probe to change the plane of view
allows for differentiation of a large vessel from a
stimulated follicle (Fig.5.3a–d).
A discussion of anticipated blood loss should
take place prior to surgery with the full multidisciplinary surgical team so that a plan may be
devised for intraoperative blood loss monitoring
and resuscitation as needed. In hysteroscopic
procedures, excess blood loss is easily recognized as the visual eld is rapidly obscured by
high-volume bleeds. In complex open or minimally invasive surgeries, intraoperative blood
loss may be more insidious, and strict monitoring
is needed. The surgeon should monitor for signs
of uterine atony and evolving coagulopathy,
which may develop in response to as well as precipitate further blood loss. Frequent closed-loop
communication between the surgeon, nursing,
and anesthesiology staff allows for timely
response to blood loss with resuscitation with

46
J. Reckhow and Z. Khan
intravenous hydration, blood products, and vasopressor support to maintain hemodynamic stability. In these cases, it is essential to perform serial
assessments of complete blood counts as well as
coagulation proles, as signicant blood loss
may precipitate coagulopathy or even disseminated intravascular coagulation (DIC), requiring
judicious repletion of clotting factors [16, 17].
Vascular injuries should be repaired by an experienced surgeon. Minor low-volume oozing may
be managed with direct pressure, cauterization of
the vessel with monopolar or bipolar energy,
suturing of the vessel, or application of hemostatic agents. Mechanical hemostatic agents
come in a variety of forms (cloth, powder, foam,
or sponge) and tend to be less costly than biologic agents. These agents work by establishing a
scaffold for platelet adherence and activation [18,
Management
19]. Biologic hemostatic agents act directly on
the common pathway of the coagulation cascade
In the event of hemorrhage, immediate direct
pressure tamponade affords the surgeon time to
plan management. If the source of the hemorrhage is visualized, the offending vessel may be
tamponaded directly. If unable to identify the
source of hemorrhage, temporary tamponade of
the internal iliac vessels or even the common iliac
vessels can afford the surgeon time to clear the
surgical eld to identify the source of bleeding.
Table 5.1 Hemostatic Agents
Agent Mechanism of action Advantages Limitations
Mechanical agents
Oxidative
regenerating
cellulose
Microbrillar
collagen
Hydrocolloid
gelatin matrix
Polysaccharide
spheres
Scaffold for platelet aggregation
Establishes acidic environment that
induces local vasoconstriction
Bactericidal
Scaffold for platelet adherence and
activation
Direct pressure from weight of the
agent (absorb 35–45 times their
weight in uid)
Absorbs water content from blood,
increasing concentration of
platelets and proteins to accelerate
intrinsic clotting cascade
to form a brin clot. These agents may require
thawing or reconstitution by a trained operator
prior to use [18, 20]. Table5.1 outlines common
hemostatic agents used in gynecologic surgery
[18].
Most bleeding after oocyte retrieval is selflimited, and typically close observation with
serial hemoglobin assessment is the primary
management strategy in this scenario.
Pliable so can be
passed through
laparoscopic trocars
Less expensive
Less expensive
Comes in multiple
forms (powder,
sheet)
May be used with
biologic agents
Less expensive
Powder form allows
for diffuse
application
Not immunogenic
Rapidly absorbed
Acidic environment inactivates
biologic hemostatic agents, so
this must be used alone or with
other mechanical agents only
Delayed absorption; can be
mistaken for abscess or
malignancy on imaging
Can be sticky and difcult to
handle
Increased risk of abscess
formation
Bovine-derived and may be
immunogenic
Porcine-derived and may be
immunogenic
Increased risk of abscess
formation
Large doses (>50g) may
precipitate hyperglycemia
(continued)

5 Uterine Surgery forInfertility
Table 5.1 (continued)
Agent Mechanism of action Advantages Limitations
Biologic agents
Thrombin Activates factors V, VIII, and XI
Thrombin +
gelatin
Fibrin Stabilizes clot by forming
Promotes platelet activation
Converts brinogen to brin
Combined effects of thrombin and
gelatin agents
insoluble brin mesh scaffold for
platelet organization
Effect is immediate Black box warning against
repeated use of bovine-derived
thrombin as it is highly
immunogenic
May transmit blood-borne disease
Effect is immediate Increased risk of small bowel
obstruction (POD#5–9)
Gentle irrigation is required to
remove excess matrix after
application to reduce adhesive
disease formation
Delayed absorption; can be
mistaken for abscess or
malignancy on imaging
Effect is immediate Expensive
47
Formation ofIntrauterine Adhesive
Disease
Background
The formation of intrauterine scar tissue is a
dreaded complication after uterine instrumentation and curettage, particularly after management
of rst or second trimester pregnancy loss or
retained placenta after delivery [21]. The true
prevalence of intrauterine adhesive disease (IUA)
and Asherman’s syndrome (IUA formation after
instrumentation of a gravid uterus) is unknown,
as the condition may be asymptomatic [22]. The
risk of scar tissue formation is highest after
instrumentation of the postpartum uterus, with
most risk occurring between the 2nd and 4th
week postpartum (19–27%) [23–25] or after rst
trimester pregnancy loss (19%) [26]. Intrauterine
adhesive disease may also develop after uterine
septoplasty, extensive hysteroscopic myomectomy, and abdominal myomectomy with entry
into the endometrial cavity [27]. Tissue ischemia
secondary to uterine artery embolization or pelvic radiation may also induce intrauterine adhesion formation [28].
Prevention
When considering strategies to prevent intrauterine adhesion formation, it is important to consider
both primary prevention as well as secondary prevention after surgical resection of existing adhesive disease. Unfortunately, the optimal approach
to prevent IUA formation remains unknown [29,
30]. Hysteroscopic tissue resection for pregnancy
loss or retained products of conception may
decrease the risk of intrauterine adhesion formation (primary prevention) as compared to traditional blind curettage; however, data in this area
remain mixed [31]. Secondary prevention after
surgical resection of existing disease can be provided with placement of a solid barrier such as a
Foley catheter balloon to prevent adhesion formation within the endometrium, although studies
investigating the utility of this have not shown a
clear reduction in intrauterine adhesion formation
or subsequent pregnancy outcomes [32–34].
Limited evidence suggests that semisolid barriers
such as hyaluronic acid gels or delayed absorbable
adhesion barriers such as carboxymethylcellulose
may decrease postoperative IUA formation [35,
36]. The role of hormonal treatments in reducing
IUA formation remains to be determined [37, 38].
Соседние файлы в папке Библиотека им академика М.И. Перельмана
